Richard O'Brien

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective

Gerald F Watts, David R Sullivan, David L Hare, Karam M Kostner, Ari E Horton, Damon A Bell, Tom Brett, Ronald J Trent, Nicola K Poplawski, Andrew C Martin, Shubha Srinivasan, Robert N Justo, Clara K Chow, Jing Pang, Zanfina Ademi, Justin J Ardill, Wendy Barnett, Timothy R Bates, Lawrence J Beilin, Warrick Bishop, et al.

Journal article  |  2021  |  American Journal of Preventive Cardiology

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

Gerald F Watts, David R Sullivan, David L Hare, Karam M Kostner, Ari E Horton, Damon A Bell, Tom Brett, Ronald J Trent, Nicola K Poplawski, Andrew C Martin, Shubha Srinivasan, Robert N Justo, Clara K Chow, Jing Pang

Journal article  |  2021  |  Heart Lung and Circulation

Familial hypercholesterolaemia (FH) is a dominant and highly penetrant monogenic disorder present from birth that markedly elevate..

Gaps in the Care of Familial Hypercholesterolaemia in Australia: First Report From the National Registry

Jing Pang, David R Sullivan, David L Hare, David M Colquhoun, Timothy R Bates, Jacqueline DM Ryan, Warrick Bishop, John R Burnett, Damon A Bell, Leon A Simons, Sam Mirzaee, Karam M Kostner, Paul J Nestel, Andrew M Wilson, Richard C O'Brien, Edward D Janus, Peter M Clifton, Justin J Ardill, Dick C Chan, Frank van Bockxmeer, et al.

Journal article  |  2021  |  Heart Lung and Circulation

BACKGROUND: Familial hypercholesterolaemia (FH) is under-diagnosed and under-treated worldwide, including Australia. National regi..

Lipoprotein apheresis andPCSK9inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand

Michael M Page, Elif Ekinci, John R Burnett, Amanda J Hooper, Nicola Reid, Warrick Bishop, Chris M Florkowski, Russell Scott, Richard C O'Brien, Gerald F Watts

Journal article  |  2021  |  Journal of Clinical Apheresis

Introduction Severe familial hypercholesterolaemia (FH) causes premature disability and death due to atherosclerotic cardiovascula..

The Prevalence of Elevated Lipoprotein(a) in Patients Presenting With Coronary Artery Disease

Hnin P Oo, Julian Giovannucci, Richard C O'Brien, David L Hare

Journal article  |  2020  |  Heart Lung and Circulation

BACKGROUND: Elevated lipoprotein(a) (Lp(a)) is an inherited lipid disorder and an independent risk factor for cardiovascular (CV) ..

Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

Jian-Jun Li, Hui-Hui Liu, Na-Qiong Wu, Khung Keong Yeo, Kathryn Tan, Junya Ako, Rungroj Krittayaphong, Ru San Tan, Philip E Aylward, Sang Hong Baek, Jamshed Dalal, Alan Yean Yip Fong, Yi-Heng Li, Richard C O'Brien, Tien Siang Eric Lim, Si Ya Natalie Koh, Daniel J Scherer, Hayato Tada, Vernon Kang, Julie Butters, et al.

Journal article  |  2020  |  Expert Opinion on Drug Metabolism & Toxicology

INTRODUCTION: Statins have been established as the standard of care for dyslipidemia and preventing cardiovascular diseases while ..

Journal clubs in Australian medical schools: prevalence, application and educator opinion

Damian James Ianno, Kelly Mirowska-Allen, Stephen Anthony Kunz, Richard O'Brien

Journal article  |  2020  |  Journal of Educational Evaluation for Health Professions

What is new in lipid-lowering therapies in diabetes?

Yee-Ming Cheung, Richard O'Brien, Elif I Ekinci

Journal article  |  2019  |  Internal Medicine Journal

Diabetes can lead to a myriad of microvascular and macrovascular complications - with the leading cause of mortality in diabetes b..

Status of PCSK9 Monoclonal Antibodies in Australia

Daniel J Scherer, Adam J Nelson, Richard O'Brien, Karam M Kostner, David L Hare, David M Colquhoun, Philip J Barter, Philip Aylward, Stephen J Nicholls, Gerald F Watts

Journal article  |  2019  |  Heart Lung and Circulation

Proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies (mAb) have progressed from showing marked low density ..

THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLAEMIA IN PATIENTS PRESENTING WITH CLINICAL CORONARY ARTERY DISEASE

J Giovannucci, H Oo, R O'Brien, D Hare

Conference Proceedings  |  2019  |  Atherosclerosis